KESSLER RC, 1994, Results from the National Comorbidity Survey. Arch. Gen. Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002
DEVANE CL, 1999, Cell Mol. Neurobiol., 1, 0443, 10.1023/A:1006934807375
PRESKORN SH, 1994, Psychopharmacol. Bull., 30, 251
SOLAI LK, 1997, J. Clin. Psychiatry, 5, 10440
10.1002/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9
AGUGLIA E, 1993, Int. Clin. Psychopharmacol, 8, 197, 10.1097/00004850-199300830-00010
LINDEN RD, NEWHOUSE P, KRISHMAN KR et al.: SSRIs inthe depressed elderly: a double-blind comparison of sertraline and fluoxetine in depressed geriatric patients. 148th Annual Meeting of the American Psychi-atric Association. Miami, FL, USA (1995).
VAN MOFFAERT M, 1995, Hum. Psychopharmacol, 10, 393, 10.1002/hup.470100505
NEMEROFF CB, 1995, Depression, 3, 163, 10.1002/depr.3050030402
RAPAPORT MH, 1998, Psychopharmacol Bull., 34, 183
SHEIKH JI, 2000, Int. Clin. Psychopharmacol., 15, 335, 10.1097/00004850-200015060-00004
CONNOR KM, 1999, Random-ised, double-blind study. Br. J. Psychiatry, 175, 17
BRADY K, 2000, JAMA, 283, 101837, 10.1001/jama.283.14.1837
BRADY KT, 1995, J Clin. Psychiatry, 56, 502
ROTHBAUM BO, 1996, J. Trauma Stress, 9, 865, 10.1002/jts.2490090414
CHOUINARD G, 1990, Psycho-pharmacol Bull., 26, 279
10.1001/archpsyc.1995.03950160039008
BISSERBE J, WISEMAN R, GOLDBERG M: Sertralineversus clomipramine in OCD. American Psychiatric Association Annual Meeting. Miami, FL, USA (1995).
HOEHN-SARIC R, 2000, Arch. Gen. Psychiatry, 57, 76, 10.1001/archpsyc.57.1.76
MARTINS EA, 1994, Anxiety, 1, 291, 10.1002/anxi.3070010609
MUNJACK DJ, 1994, Anxiety, 1, 196, 10.1002/anxi.3070010409
CZEPOWICZ VD, 1995, J. Clin. Psychopharmacol, 15, 372, 10.1097/00004714-199510000-00011
10.1016/S0140-6736(00)02754-9
PEARLSTEIN TB, 2000, J an. Psychiatry, 61, 101
BERGH C, 1996, Lancet, 348, 1459, 10.1016/S0140-6736(04)70113-0
10.1176/appi.ajp.157.6.1004
HIGLEY J, 1998, Neuropsychopharmacology, 18, 431, 10.1016/S0893-133X(97)00180-2
NARANJO CA, 1990, Pharmacol. Ther., 47, 490, 10.1038/clpt.1990.62
GORELICK DA, 1992, Alcohol Clin. Exp. Res., 16, 261, 10.1111/j.1530-0277.1992.tb01373.x
KABEL DI, 1996, Alcohol Clin. Exp. Res., 20, 780, 10.1111/j.1530-0277.1996.tb01686.x
KRANZLER HR, 1995, Am. J. Psychiatry, 152, 391, 10.1176/ajp.152.3.391
10.1001/archpsyc.1997.01830200024004
10.1016/S0006-3223(97)00509-X
10.1111/j.1530-0277.2000.tb04648.x
FARREN CK, 2000, CNS Spectrums, 5, 70, 10.1017/S1092852900012839
MASON BJ, WILLIAMS LD, SALVATO FR et al.: Naltrex one and/or sertraline in comorbid depression and alcoholism. Research Society on Alcoholism Annual Meeting. Denver, CO, USA (1998).
10.3109/10550499208993155
POLLACK MH, 1991, J Clin. Psychiatry, 52, 31
10.1016/0376-8716(96)01233-1
10.3109/00952999509002701
10.1097/00004714-199506000-00004
PEETRAKIS I, 1998, Drug Alcohol Depend., 50, 221, 10.1016/S0376-8716(98)00032-5
EDWARDS JG, 1999, Drugs, 57, 507, 10.2165/00003495-199957040-00005
GRIMSLEY SR, 1992, Pharm., 11, 930
GOLDBERG RJ, 1998, Arch. Fam. Med., 7, 78, 10.1001/archfami.7.1.78
MADHUSOODANAN S, 1997, j Clin. Psychophar-macol., 17, 138, 10.1097/00004714-199704000-00026
LAPORTA LD, 1993, J. Clin. Psychopharmacol, 13, 219, 10.1097/00004714-199306000-00013
SETTLE EC, 1993, j Clin. Psychiatry, 54, 321
ALTSHULER LL, 1994, J. Clin. Psychopharmacol., 14, 278, 10.1097/00004714-199408000-00010
LIPINSKI JF, 1989, J. Clin. Psychiatry, 50, 339
HAMILTON MS, 1992, j Clin. Psychiatry, 53, 401
CALHOUN JW, 1996, Am. J. Psychiatry, 153, 443
ZAJECKA J, 1997, J. Clin. Psychiatry, 58, 291, 10.4088/JCP.v58n0702
STAHL MM, 1997, Eur.J. Clin. Pharmacol., 53, 163, 10.1007/s002280050357
LYDIARD RB, 1993, Am. J. Psychiatry, 150, 1125
BARROS J, 1993, Am. J. Psychiatry, 150, 1751
CHONG SA, 1997, J. Clin. Psycho-pharmacol, 17, 68, 10.1097/00004714-199702000-00024
10.1177/026988119901300111
10.1097/00005792-200007000-00001
SPORER KA, 1995, Implicated drugs, pathophysiology and management. Drug Sal, 13, 94
